The pathogenic role of circulating Hashimoto's Thyroiditis-derived TPO-positive IgG on fetal loss in naïve mice.


Journal

American journal of reproductive immunology (New York, N.Y. : 1989)
ISSN: 1600-0897
Titre abrégé: Am J Reprod Immunol
Pays: Denmark
ID NLM: 8912860

Informations de publication

Date de publication:
01 2021
Historique:
received: 30 04 2020
revised: 09 07 2020
accepted: 12 08 2020
pubmed: 8 9 2020
medline: 6 10 2021
entrez: 7 9 2020
Statut: ppublish

Résumé

Antibody-mediated autoimmune diseases, such as autoimmune thyroid diseases (ATD), systemic lupus erythematosus (SLE), and antiphospholipid syndrome (APS), often are associated with recurrent fetal loss. One of the ATD is Hashimoto's thyroiditis which recently showed association with complications of pregnancy with increased levels of circulating autoantibodies reactive with epitopes on thyroid tissue such as thyroid peroxidase (anti-TPO). In retrospective study of sera analyses in patients with Hashimoto's thyroiditis, all patients had mainly elevated circulating anti-TPO autoantibodies. We assessed the potential of human anti-TPO highly positive IgG, derived from patients with Hashimoto's thyroiditis sera associated with complications of pregnancy, to cause directly complications of pregnancy in murine model. Naïve ICR female mice, infused intravenously with 100 μg of anti-TPO-positive IgG, showed increased fetal loss and embryo small for date (P < .001) in comparison with mice passively transferred with commercial IgG or PBS. Moreover, we observed embryos small for date in the mice passively transferred with anti-TPO-positive IgG, exemplified by reduced weight of embryos and placentae (P = .001). Histopathological examination revealed delay in fetal development in 50% cases of anti-TPO-positive IgG-treated mice. Importantly, pathological changes in the transition zone, state of glycogen cells, and significant structural changes in the labyrinth part of placenta were observed in all anti-TPO-positive IgG samples. The current study shows in the first time, a direct proof of concept, on the association of human TPO-positive IgG from Hashimoto's thyroiditis patients on fetal loss induction in murine model.

Identifiants

pubmed: 32893404
doi: 10.1111/aji.13331
doi:

Substances chimiques

Autoantibodies 0
Autoantigens 0
Immunoglobulin G 0
Iron-Binding Proteins 0
anti-thyroid autoantibodies 0
TPO protein, human EC 1.11.1.7
Iodide Peroxidase EC 1.11.1.8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13331

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Dallas JS. Autoimmune thyroid disease and pregnancy: relevance for the child. Autoimmunity. 2003;36:339-350.
Stagnaro-Green A, Roman SH, Cobin RH, El-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA. 1990;264:1422-1425.
Glinoer D, Soto MF, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab. 1991;73:421-427.
Lee YL, Ng HP, Lau KS, et al. Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model. Fert Ster. 2009;91:2104-21499.
Marai I, Carp H, Shai S, Shabo R, Fishman G, Shoenfeld Y. Autoantibody panel screening in recurrent miscarriages. Am J Reprod Immunol. 2004;51(3):235-240.
Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endoc Rev. 2001;22:605-630.
Montoro MN. Management of hypothyroidism during pregnancy. Clin Obst Gynecol. 1997;40:65-80.
Matalon ST, Blank M, Levy Y, et al. The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Human Reprod. 2003;18:1094-1099.
Ghafoor F, Mansoor M, Malik T, et al. Role of thyroid peroxidase antibodies in the outcome of pregnancy. J College Phys Surg-Pakistan. 2006;16:468-471.
Poppe K, Glinoer D, Tournaye H, et al. Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metabo. 2003;88:4149-4152.
Negro R, Formoso G, Coppola L, et al. Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function. J Endocrinol Investig. 2007;30:3-8.
Singh A, Dantas ZN, Stone SC, Asch RH. Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fert Ster. 1995;63:277-281.
Yang G, Wu P, Sun Y, et al. Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis. Semin Arthritis Rheum. 2020;50(4):534-543.
Cavalcante MB, Cavalcante CTMB, Sarno M, et al. Antinuclear antibodies and recurrent miscarriage: Systematic review and meta-analysis. Am J Reprod Immunol. 2020;83(3):e13215.
Ochi I, Horiuchi N, Araki T, et al. Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy. FEBS Lett. 2002;528:197-202.
Benvenga S, Guarneri F, Benvenga S. Homology between TSH-R/Tg/TPO and Hashimoto's encephalopathy autoantigens. Front Biosci (Landmark Ed). 2020;1(25):229-241.
Kishitani T, Matsunaga A, Ikawa M, et al. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy. Medicine (Baltimore). 2017;96(10):e6181.

Auteurs

Elena Borodina (E)

Laboratory of the Mosaic of Autoimmunity, Department of Obstetrics, Gynecology and Reproductive Sciences, Saint Petersburg State University, Saint Petersburg, Russia.
Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint Petersburg, Russia.

Itai Katz (I)

Zabludowicz Center for Autoimmune Diseases; Sheba Medical Center; Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Alessandro Antonelli (A)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Alexander M Gzgzyan (AM)

Laboratory of the Mosaic of Autoimmunity, Department of Obstetrics, Gynecology and Reproductive Sciences, Saint Petersburg State University, Saint Petersburg, Russia.

Liailia Kh Dzhemlikhanova (LK)

Laboratory of the Mosaic of Autoimmunity, Department of Obstetrics, Gynecology and Reproductive Sciences, Saint Petersburg State University, Saint Petersburg, Russia.

Yuri Ostrinski (Y)

Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint Petersburg, Russia.
Zabludowicz Center for Autoimmune Diseases; Sheba Medical Center; Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Dariko Niauri (D)

Laboratory of the Mosaic of Autoimmunity, Department of Obstetrics, Gynecology and Reproductive Sciences, Saint Petersburg State University, Saint Petersburg, Russia.
Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint Petersburg, Russia.

Jamilya Khizroeva (J)

Department of Obstetrics and Gynaecology, Sechenov University, Moscow, Russia.

Victoria Bitsadze (V)

Department of Obstetrics and Gynaecology, Sechenov University, Moscow, Russia.

Alexander Makatsariya (A)

Department of Obstetrics and Gynaecology, Sechenov University, Moscow, Russia.

Angela Tincani (A)

Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy.
Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation.

Cecilia Nalli (C)

Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy.
Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Leonid P Churilov (LP)

Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint Petersburg, Russia.

Ora Shovman (O)

Zabludowicz Center for Autoimmune Diseases; Sheba Medical Center; Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Gilad Halpert (G)

Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint Petersburg, Russia.
Zabludowicz Center for Autoimmune Diseases; Sheba Medical Center; Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Miri Blank (M)

Zabludowicz Center for Autoimmune Diseases; Sheba Medical Center; Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yehuda Shoenfeld (Y)

Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint Petersburg, Russia.
Zabludowicz Center for Autoimmune Diseases; Sheba Medical Center; Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Howard Amital (H)

Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint Petersburg, Russia.
Zabludowicz Center for Autoimmune Diseases; Sheba Medical Center; Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of Medicine B, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH